NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/23/2024
Back to search
Official data from USPTO
XALUDICIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
07/23/2024
Trademark type
Word
Nice classes
5
Filing date
07/08/2014
Registration date
01/09/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/23/2024
Last transaction
07/23/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
16
Owner location
Hitchin, Hertfordshire, GB
Examiner
RINKER, ANTHONY
Current location
Historical data usage
Holders and representatives
Holders
InQpharm Europe Limited
InQpharm Europe Limited
Representatives
Mark D. Swanson Pauley Erickson & Swanson
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsfor treatment of immune system supportcardiovascular system supportcholesterol controlblood pressure controlanti-infectiveanti-inflammatoryjoint healthenergy boostingblood sugar control and cancer treatment; Plant extracts for dieteticnutraceutical or pharmaceutical use for the treatment of immune system supportcardiovascular system supportcholesterol controlblood pressure controlanti-infectiveanti-inflammatoryjoint healthenergy boostingblood sugar control and cancer treatment; health and medical food supplements derived from plants for the treatment of immune system supportcardiovascular system supportcholesterol controlblood pressure controlanti-infectiveanti-inflammatoryjoint healthenergy boostingblood sugar control and cancer treatment; food for babies; dietary supplements for humans and animals; plasters for medical purposes; all the aforesaid excluding goods for the treatment of acute lymphoblastic leukemia
Publications
History of USPTO decisions and trademark events.
47 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/23/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/23/2024
E815
TEAS SECTION 8 & 15 RECEIVED
01/09/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/09/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/24/2017
PUBO
PUBLISHED FOR OPPOSITION
10/24/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/04/2017
CNEA
EXAMINERS AMENDMENT MAILED
09/21/2017
ADBS
1(B) BASIS DELETED; NEW BASIS REQUESTED
09/21/2017
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
09/11/2017
APET
ASSIGNED TO PETITION STAFF
09/07/2017
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/24/2017
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
08/24/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/09/2017
EX5G
SOU EXTENSION 5 GRANTED
06/08/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/07/2017
EXT5
SOU EXTENSION 5 FILED
05/22/2017
EEXT
SOU TEAS EXTENSION RECEIVED
05/22/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/29/2016
EX4G
SOU EXTENSION 4 GRANTED
11/28/2016
EXT4
SOU EXTENSION 4 FILED
10/27/2016
EEXT
SOU TEAS EXTENSION RECEIVED
10/27/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/19/2016
EX3G
SOU EXTENSION 3 GRANTED
05/18/2016
EXT3
SOU EXTENSION 3 FILED
05/16/2016
EEXT
SOU TEAS EXTENSION RECEIVED
05/16/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/10/2015
EX2G
SOU EXTENSION 2 GRANTED
12/09/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/09/2015
EXT2
SOU EXTENSION 2 FILED
11/17/2015
EEXT
SOU TEAS EXTENSION RECEIVED
11/17/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/17/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/21/2015
EX1G
SOU EXTENSION 1 GRANTED
05/20/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/20/2015
EXT1
SOU EXTENSION 1 FILED
04/22/2015
EEXT
SOU TEAS EXTENSION RECEIVED
04/22/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/25/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/30/2014
PUBO
PUBLISHED FOR OPPOSITION
09/30/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/10/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/20/2014
DOCK
ASSIGNED TO EXAMINER
08/20/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2014
NWAP
NEW APPLICATION ENTERED
07/11/2014
Continuous trademark protection
Get notified about every new filing that threatens XALUDICIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.